Literature DB >> 16522381

Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients.

K Hisamuddin1, N A G Mowat, P S Phull.   

Abstract

BACKGROUND: Detection of faecal occult blood is recommended for colorectal cancer screening in average risk populations. However, many subjects do not have any cause found in the colon to account for the occult blood loss. AIMS: To determine the prevalence of upper gastrointestinal tract disease in faecal occult blood-positive, colonoscopy-negative patients. PATIENTS AND METHODS: Retrospective audit of 99 patients (56 females; mean age 60 years, range 18-83) who underwent same-day colonoscopy and upper gastrointestinal endoscopy over a 2-year period.
RESULTS: Fifty-two of the 99 patients had a normal colonoscopy, 16 had diverticulosis and 2 had hyperplastic polyps; these 70 patients comprised the colonoscopy-negative group. Significant upper gastrointestinal tract disease was noted in 25 (36%) of the colonoscopy-negative group compared with 10 (34%) of the 29 colonoscopy-positive group (p=ns). Most of the upper gastrointestinal tract lesions identified were benign. Within the colonoscopy-negative group, patients with anaemia or upper gastrointestinal tract symptoms had a higher prevalence of positive findings in the upper gastrointestinal tract, but this association was not statistically significant.
CONCLUSIONS: Endoscopic examination of the upper gastrointestinal tract in faecal occult blood-positive individuals reveals mostly benign disease, with an equal prevalence in colonoscopy-negative and colonoscopy-positive patients. Routine performance of upper gastrointestinal endoscopy in faecal occult blood-positive individuals is not indicated and should be undertaken only for appropriate symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16522381     DOI: 10.1016/j.dld.2006.01.021

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  6 in total

1.  Positive occult blood and negative colonoscopy--should we perform gastroscopy?

Authors:  Mark T McLoughlin; Jennifer J Telford
Journal:  Can J Gastroenterol       Date:  2007-10       Impact factor: 3.522

2.  Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.

Authors:  Tsung-Hsien Chiang; Yi-Chia Lee; Chia-Hung Tu; Han-Mo Chiu; Ming-Shiang Wu
Journal:  CMAJ       Date:  2011-08-02       Impact factor: 8.262

3.  Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test.

Authors:  Lukejohn W Day; John P Cello; Ma Somsouk; John M Inadomi
Journal:  Indian J Gastroenterol       Date:  2011-09-23

Review 4.  Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline.

Authors:  Johane Allard; Roxanne Cosby; M Elisabeth Del Giudice; E Jan Irvine; David Morgan; Jill Tinmouth
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

5.  A nine-year audit of open-access upper gastrointestinal endoscopic procedures: results and experience of a single centre.

Authors:  Dean Keren; Tova Rainis; Edy Stermer; Alexandra Lavy
Journal:  Can J Gastroenterol       Date:  2011-02       Impact factor: 3.522

6.  High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopy.

Authors:  Jeremy P Brown; Kate Wooldrage; Suzanne Wright; Claire Nickerson; Amanda J Cross; Wendy S Atkin
Journal:  J Med Screen       Date:  2017-05-03       Impact factor: 2.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.